Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.
2.

The usefulness of p63 as a marker of breast myoepithelial cells.

Batistatou A, Stefanou D, Arkoumani E, Agnantis NJ.

In Vivo. 2003 Nov-Dec;17(6):573-6. Review.

PMID:
14758723
3.

Detection of stromal invasion in breast cancer: the myoepithelial markers.

Yaziji H, Gown AM, Sneige N.

Adv Anat Pathol. 2000 Mar;7(2):100-9. Review.

PMID:
10721417
4.

[Diagnostic immunohistochemistry of breast epithelial lesions].

Balaton AJ, Guinebretière JM, Penault-Llorca F.

Ann Pathol. 2003 Dec;23(6):570-81. Review. French.

PMID:
15094595
5.
6.

Invasive breast carcinoma arising in microglandular adenosis: a case report and review of the literature.

Shui R, Yang W.

Breast J. 2009 Nov-Dec;15(6):653-6. doi: 10.1111/j.1524-4741.2009.00839.x. Epub 2009 Oct 12. Review.

PMID:
19824997
7.

The role of immunohistochemistry in the differential diagnosis of papillary lesions of the breast.

Tse GM, Tan PH, Moriya T.

J Clin Pathol. 2009 May;62(5):407-13. doi: 10.1136/jcp.2008.063016. Epub 2009 Jan 6. Review.

PMID:
19126567
8.

Preneoplasia of the breast.

Böcker W.

Verh Dtsch Ges Pathol. 1997;81:502-13. Review.

PMID:
9474891
9.

Taking advantage of basic research: p63 is a reliable myoepithelial and stem cell marker.

Reis-Filho JS, Schmitt FC.

Adv Anat Pathol. 2002 Sep;9(5):280-9. Review.

PMID:
12195217
10.

Use of immunohistochemistry in the diagnosis of problematic breast lesions.

Lee AH.

J Clin Pathol. 2013 Jun;66(6):471-7. doi: 10.1136/jclinpath-2012-201109. Epub 2013 Mar 13. Review.

PMID:
23486609
11.

Histiocytoid breast carcinoma: histological, immunohistochemical, ultrastructural, cytological and clinicopathological studies.

Shimizu S, Kitamura H, Ito T, Nakamura T, Fujisawa J, Matsukawa H.

Pathol Int. 1998 Jul;48(7):549-56. Review.

PMID:
9701019
12.

Use of Myoepithelial Cell Markers in the Differential Diagnosis of Benign, In situ, and Invasive Lesions of the Breast.

Corben AD, Lerwill MF.

Surg Pathol Clin. 2009 Jun;2(2):351-73. doi: 10.1016/j.path.2009.02.003. Epub 2009 Jun 2. Review.

PMID:
26838326
13.

Pathology of preinvasive and excellent-prognosis breast cancer.

Page DL, Simpson JF.

Curr Opin Oncol. 1996 Nov;8(6):462-7. Review.

PMID:
8971465
14.

The histologic spectrum of apocrine lesions of the breast.

Durham JR, Fechner RE.

Am J Clin Pathol. 2000 May;113(5 Suppl 1):S3-18. Review.

PMID:
11993707
15.

Eosinophilic and granular cell tumors of the breast.

Damiani S, Dina R, Eusebi V.

Semin Diagn Pathol. 1999 May;16(2):117-25. Review.

PMID:
10452577
16.

[Invasive carcinoma arising in breast microglandular adenosis: a clinicopathologic study of three cases and review of the literature].

Shui RH, Cheng YF, Yang WT.

Zhonghua Bing Li Xue Za Zhi. 2011 Jul;40(7):471-4. Review. Chinese.

PMID:
22088374
17.

Stages on the way to breast cancer.

Going JJ.

J Pathol. 2003 Jan;199(1):1-3. Review.

PMID:
12474219
18.
19.

Myoepithelial cells: autocrine and paracrine suppressors of breast cancer progression.

Barsky SH, Karlin NJ.

J Mammary Gland Biol Neoplasia. 2005 Jul;10(3):249-60. Review.

PMID:
16807804
20.

Borderline breast lesions: diagnostic challenges and clinical implications.

Masood S, Rosa M.

Adv Anat Pathol. 2011 May;18(3):190-8. doi: 10.1097/PAP.0b013e31821698cc. Review.

PMID:
21490436

Supplemental Content

Support Center